Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway

Oncogene

Volumn 14, Issue 2, 1997, Pages 203-212

  Bies, Juraj ^a,b   Wolff, Linda ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

26S proteasome; c Myb; PEST sequence; Proteolytic stability; Ubiquitin

Indexed keywords

CALPAIN; CHLOROQUINE; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MUTANT PROTEIN; ONCOPROTEIN; PROTEASOME; SULFUR 35; TRANSCRIPTION FACTOR; UBIQUITIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE ACTIVATION; HALF LIFE TIME; ISOTOPE LABELING; MOUSE; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; RETROVIRUS; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0031014535     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200828     Document Type: Article

References (48)

1. Aziz N, Miglarese MR, Hendrickson RC, Shabanowitz J, Sturgill TW, Hunt DF and Bender TP. (1995). Proc. Natl. Acad. Sci. USA, 92, 6429-6433.
2. Bender TP and Kuehl MW. (1986). Proc. Natl. Acad. Sci. USA, 83, 3204-3208.
3. Biedenkapp H, Borgmeyer U, Sippel AE and Klempnauer KH. (1988). Nature, 355, 835-837.
4. Bies J, Mukhopadhyaya R, Pierce J and Wolff L. (1995). Cell Growth & Differ., 6, 59-68.
5. Bics J, Hoffman B, Amanullah A, Giese T and Wolff L. (1996). Oncogene, 12, 355-363.
6. Ciechanover A. (1994). Cell, 79, 13-21.
7. Ciechanover A, Shkedy D, Oren M and Bercovich B. (1994). J. Biol. Chem., 269, 9582-9589.
8. Crook T and Vousden KH. (1992) EMBO J., 11, 3935-3940.
9. Dini PW and Lipsick JS. (1993). Mol. Cell. Biol., 13, 7334-7348.
10. Ferrao P, Macmillan EM, Ashman LK and Gonda TJ. (1995). Oncogene, 11, 1631-1638.
11. Foos G, Grimm S and Klempnauer KH. (1992). EMBO J., 11, 4619-4629.
12. Fort P. Piechaczyk M, Sabrouty S, Dani C, Jeanteur P and Blanchard J. (1985). Nucleic Acids Res., 13, 1431-1437.
13. Hochstrasser M. (1995). Curr. Opin. Cell Biol., 7, 215-223.
14. Howc KM, Reakes CFL and Watson RJ. (1990). EMBO J., 9, 161-169.
15. Hu YL, Ramsay RG, Kanei-Ishii C, Ishii S and Gonda TJ. (1991). Oncogene, 6, 1549-1533.
16. Ibanez CE and Lipsick JS. (1990). Mol. Cell. Biol., 10, 2285-2293.
17. Introna M, Luchetti M, Castellano M, Arsura M and Golay J. (1994). Seminars in Cancer Biol., 5, 113-124.
18. Kalkbrenner F, Guehmann S and Moelling K. (1990) Oncogene, 5, 657-661.
19. Kanei-Ishii C, MacMillan EM, Nomura T, Sarai A, Ramsay RG, Aimoto S, Ishii S and Gonda TJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 3088-3092.
20. Klempnauer KH and Sippel AE. (1987). EMBO J., 6, 2719-2725.
21. Kornitzer D, Raboy B, Kulka RG and Fink GR. (1994). EMBO J., 13, 6021-6030.
22. Liebermann DA and Hoffman-Liebermann B. (1989). Oncogene, 4, 583-592.
23. Lin R, Beauparlant P, Makris C, Meloche S and Hiscott J. (1996). Mol. Cell. Biol., 16, 1401-1409.
24. Lüscher B and Eisenman RN. (1988). Mol. Cell. Biol., 8, 2504-2512.
25. Lüscher B and Eisenman RN. (1990). Genes Gev, 4, 2235-2241.
26. Markowitz D, Goff S and Bank A. (1988a). Virology, 167, 400-406.
27. Markowitz D, Goff S and Bank A. (1988b). J. Virol., 62, 1120-1124.
28. Miller AD and Rosman GJ. (1989). Biotechniques, 9, 980-986.
29. Mukhopadhyaya R and Wolff L. (1992). J. Virol., 66, 6035-6044.
30. Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G and Ishii S. (1992). Oncogene, 7, 1233-1240.
31. Nishina Y, Nakagoshi H, Imamoto F, Gonda TJ and Ishii S. (1989). Nucleic Acids Res., 17, 107-117.
32. Palombella VJ, Rando OJ, Goldberg AL and Maniatis T. (1994). Cell, 78, 773-785.
33. Papavassiliou AG, Treier M, Chavrier C and Bohmann D. (1992). Science, 258, 1941-1944.
34. Perryman S, Nishio J and Chesebro EH. (1992). Nucleic Acids Res., 19, 6950.
35. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL. (1994). Cell, 78, 761-771.
36. Rogers S, Wells A and Rechsteiner M. (1986). Science, 234, 364-368.
37. Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda T and Ishii S. (1989). Proc. Natl. Acad. Sci. USA, 86, 5758-5762.
38. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
39. Shen-Ong GLC and Wolff L. (1987). J. Virol., 61, 3721-3725.
40. Stancovski I, Gonen H, Orian A, Schwartz AL and Ciechanover A. (1995). Mol. Cell. Biol., 15, 7106-7116.
41. Treier M, Staszewski LM and Bohmann D. (1994). Cell, 78, 787-798.
42. Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N, Ichihara A and Tanaka K. (1995). Mol. Cell. Biol, 15, 5682-5687.
43. Weinstein Y, Ihle JN, Lavu S and Reddy EP. (1986). Proc. Natl. Acad. Sci. USA, 83, 5010-5014.
44. Weston K and Bishop JM. (1989). Cell, 58, 85-93.
45. Wolff L, Koller R and Davidson W. (1991). J. Virol. 65, 3607-3616.
46. Wolff L, Koller R, Bies J, Nazarov V, Huffman B, Amanullah A, Krall M and Mock B. (1996). Curr. Top. Micrbiol. Immunol., 211, 191-199.
47. Yaglom J, Linskens MHK, Sadis S, Rubin DM, Futcher B and Finley D. (1995). Mol. Cell. Biol., 15, 731-741.
48. Ymer S, Tucker WQJ, Sanderson CJ, Hapel AJ, Campbell HD and Young IG. (1985). Nature, 317, 255-258.